Tyra Biosciences, Inc. (TYRA) Misses Q4 EPS by 4c

Tyra Biosciences, Inc. (NASDAQ: TYRA) reported Q4 EPS of ($0.57), $0.04 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tyra Biosciences, Inc. (TYRA) click here.

You May Also Be Interested In

• Stifel Reiterates Buy Rating on Palo Alto Networks (PANW)
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue
• Bernstein SocGen Group Starts Americana Restaurants (AMR:UH) at Outperform